Hot Articles

Should You Buy Sio Gene Therapies (SIOX) Stock In May?

Sio Gene Therapies (NASDAQ: SIOX) stock was up by 20% since April 20 without any direct positive news from the company during this period. However, the company is focusing on the development of the drugs related to GM1 gangliosidosis, Tay-Sachs/Sandhoff disease, and Parkinson’s disease.
InvestReader Editor - May 03, 2021

Why Outlook Therapeutics (OTLK) Stock Rose In Recent Days?

Outlook Therapeutics (NASDAQ: OTLK) stock was up by 34% since April 20. The main catalyst of the stock's rise during the period due to the company insiders repurchased the company's stock on April 20, that's a positive sign.
InvestReader Editor - May 02, 2021

Is Aikido Pharma (AIKI) Stock Worth Buying?

Aikido Pharma (NASDAQ: AIKI) stock was up by only 18% so far this year. Investors seem to be waiting for the study results about its anti-cancer drugs from the company. The company's drug portfolio focuses on the treatment of four cancers, prostate cancer, pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
InvestReader Editor - May 02, 2021

Will Atossa Therapeutics (ATOS) Stock Continue To Rise After Soared 32% In A Week?

Atossa Therapeutics (NASDAQ: ATOS) stock soared by 32% over the past five trading days. Although the stock is still a penny stock, I am bullish on the stock's future. The company is a clinical-stage biopharmaceutical company and is focusing on breast cancer and COVID-19, and if it succeeds, its stock price will soar.
InvestReader Editor - May 02, 2021

Is It Time To Buy Sonnet BioTherapeutics (SONN) Stock?

Sonnet BioTherapeutics (NASDAQ: SONN) stock has continued to fall in the past year, but the stock received a lot of attention from investors last trading day. The stock was up by 18% at close last Friday, and the trading volume of that day was nearly 5 times its recent 3-month average levels. Notably, there has been no direct positive news about the company recently.
InvestReader Editor - May 02, 2021

Is American Battery Metals Corporation (ABML) Stock Worth Buying?

American Battery Metals Corporation (ABML) stock was up by 46% so far this year. This American-owned lithium-ion battery recycling and extraction company recently submitted three new permit applications to the divisions of government for continuing the permitting process for its lithium battery recycling pilot plant in Fernley, Nevada.
InvestReader Editor - May 02, 2021

Why Is CASI Pharmaceuticals (CASI) Stock Undervalued?

CASI Pharmaceuticals (NASDAQ: CASI) stock fell 37% so far this year, but I think this is an undervalued stock. There are still some reasons for investors who focused on the pharmaceutical field to continue to track the stock.
InvestReader Editor - May 01, 2021

Why Castlight Health (CSLT) Stock Worth Buying?

Castlight Health (NYSE: CSLT) stock was up by 28% over the past two trading days. Investors realized that the company's stock was still worth buying after the company released its first quarter 2021 financial results Thursday.
InvestReader Editor - May 01, 2021

Why Ault Global Holdings (DPW) Stock Rose In Recent Days?

Ault Global Holdings (NYSEAMERICAN: DPW) rose by 33% since April 21. The fourth quarter and FY 2020 earnings report was published by the company on April 16, which appeared to bring confidence to investors.
InvestReader Editor - May 01, 2021

Is Naked Brand (NAKD) Stock Worth Buying Right Now?

Naked Brand (NASDAQ: NAKD) stock soared today due to the company's shareholders have approved the divestiture of its unprofitable brick-and-mortar operations. The purpose of this move is in order to concentrate more resources to its e-commerce business.
InvestReader Editor - April 30, 2021

Is Moderna (MRNA) Stock Worth Buying After Announcing Plans To Increase Global Supply For COVID-19 Vaccine To 3 Billion Doses By 2022?

Moderna (NASDAQ: MRNA) stock was down by 1.68% at close Thursday. Those Investors who focused on the biopharmaceutical stocks were not excited about this news that published by the company on Wednesday.
InvestReader Editor - April 30, 2021

How To Value MicroVision (MVIS) Stock After Released The First Quarter 2021 Earnings Report?

MicroVision (NASDAQ: MVIS) stock fell by 14.24% at close yesterday. The company released its first quarter 2021 financial results yesterday which lowered than analyst expected.
InvestReader Editor - April 30, 2021

How To Value Nio (NIO) Stock After Released First Quarter 2021 Financial Results?

Nio (NYSE: NIO) stock fell by 5% Thursday, despite the company said it has achieved an increase of 422.7% and 481.8% YoY in vehicle deliveries and total revenue for the first quarter of 2021, respectively, still unprofitable.
InvestReader Editor - April 29, 2021

Is Carnival (CCL) Stock Worth Buying After CDC Said U.S. Cruise Could Resume Sailing By Mid-July?

Yes, that's a good news for investors who involved in Carnival (NYSE: CCL) stock as well as other cruise company stocks. The CDC said Wednesday in a letter to the cruise industry that cruise operators could begin passenger voyages from the U.S. in mid-July.
InvestReader Editor - April 29, 2021

Why Roku (ROKU) Stock Worth To Buy?

It's not without reason that Roku (NASDAQ: ROKU) stock has continued to rise over the past month. The company has been trying to raise its advertising revenue by improvements in the quality and quantity of streaming of content, also include video advertising related technologies.
InvestReader Editor - April 29, 2021

How To Trade Inovio Pharmaceuticals (INO) Stock After Losing Phase 3 Funds For COVID-19 Vaccine?

Inovio Pharmaceuticals (NASDAQ: INO) stock seems to have returned to a calm period now. The things may not be as bad as imaged when investors calm down and revalue the stock.
InvestReader Editor - April 29, 2021

Is AMC Entertainment (AMC) Stock Worth Buying In May?

AMC Entertainment (NYSE: AMC) stock fell by 5.32% due to the company said Tuesday that it plans to bolster its cash reserves through selling 43 million shares. Undoubtedly, this would have resulted in dilution to existing shareholders.
InvestReader Editor - April 28, 2021

How To Trade Ocugen (OCGN) Stock Currently, Buy or Sell?

Ocugen (NASDAQ: OCGN) stock is under selling pressure as the company issued an aggregate of 10 million shares of its common stock priced at a premium to market in recent day.
InvestReader Editor - April 28, 2021

Is Arbutus Biopharma (ABUS) Stock Worth To Buy After Rose by 15% In A Week?

Arbutus Biopharma (ABUS) stock was up by 15% in a week without any positive news about the company in recent days. In fact, the stock fell by 3% so far this year.
InvestReader Editor - April 28, 2021

Is Globalstar (GSAT) Stock Worth To Buy After Soared 39%?

Globalstar (NYSEAMERICAN: GSAT) stock soared by 39% over the past two trading days. The CEO, David Kagan of the company participated the 24th Annual Burkenroad Reports Investment Conference online last Friday and provided some information about finances, products and future plans of the company.
InvestReader Editor - April 28, 2021

Is Vaxart (VXRT) Stock Worth To Buy After Soaring 37%?

Vaxart (NASDAQ: VXRT) will be a huge success if it can prove that its oral vaccine can be as effective as or exceed other top COVID vaccines, because it's more convenient to transport and store, and it can speed up the vaccination rate.
InvestReader Editor - April 27, 2021

Is Pfizer (PFE) Stock Worth To Buy After Announced An Additional 100 Million Doses Of COVID-19 Vaccine To EU?

Pfizer (NYSE: PFE) last Monday said that it with its partner BioNTech (Nasdaq: BNTX) will supply an additional 100 million doses of COVID-19 vaccine to the 27 EU member states this year. However, Pfizer's stock rose by only 1% after this news released, and then began to fall. The rising seems to be subject to some resistance.
InvestReader Editor - April 27, 2021

Why ZOM, NAKD, AMC, OCGN And Other Reddit Stocks Soared Monday?

Yes, these are all Reddit stocks such as ZOM, NAKD, AMC, OCGN, and rose in different degree Monday.
InvestReader Editor - April 27, 2021

Will Tesla (TSLA) Stock Continue To Rise After Reported Its Total Revenue Grew 74% YoY in Q1?

Tesla (NASDAQ:TSLA) reported its Q1 2020 financial results and it shows its total revenue was $10.4 billion for the quarter, an increase of 74% year-on-year, which a total revenue of an increase of 75% in automotive sales.
InvestReader Editor - April 27, 2021

Is fuboTV (FUBO) Stock Worth To Buy Right Now?

For fuboTV (NYSE: FUBO) stock, what investors care most is the company's net revenue and net loss. Although the company said that its revenue increased 98% year-on-year in the fourth quarter of 2020, its net loss was nearly 6 times than the same period last year.
InvestReader Editor - April 27, 2021

Is Tilray (TLRY) Stock Worth To Buy After A Merger With Aphria (APHA)?

The merger of Aphria (APHA) and Tilray (TLRY) is imminent. Aphria's shareholders overwhelmingly approved the deal in a vote held on April 14. The vote meeting of Tilray‘s stockholders scheduled for April 16, and then adjourned until April 30.
InvestReader Editor - April 26, 2021

Will XpresSpa (XSPA) Stock Continue To Rebound This Week?

2020 is a bad year for XpresSpa Group (NASDAQ: XSPA) company, XpresSpa's revenue was $10.9 million in 2019, but it was only $0.3 million in 2020.
InvestReader Editor - April 26, 2021

About Rising Troubles Of Tesla (TSLA) In China

First of all, do you think that Tesla (NASDAQ: TSLA) will seize the largest share of China EV market in the future? It's not it can't do it, it may be a political question.
InvestReader Editor - April 26, 2021

Will Ocugen (OCGN) Stock Continue To Rise Next Week?

Ocugen (NASDAQ: OCGN) stock rose by over 74% since the company's COVID-19 vaccine co-development partner, Bharat Biotech, shared positive results of the Phase 3 study of COVAXIN last Wednesday.
InvestReader Editor - April 26, 2021

Should You Buy Snap (SNAP) Stock After Reported An Increase of 66% For Q1?

During the coronavirus pandemic, more people at home and choose online entertainment software to offset boring life, which benefitting Snap (NYSE: SNAP).
InvestReader Editor - April 25, 2021